Hancock Jaffe Laboratories, Inc. Contracts & Agreements
128 Contracts & Agreements
- Business Finance (85 contracts)
- Business Operations (17)
- Human Resources (21)
- Real Estate (1)
- Uncategorized (4)
- Underwriting Agreement, dated September 26, 2024, between enVVeno Medical Corporation and Titan Partners Group LLC, a division of American Capital Partners, LLC (Filed With SEC on September 30, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on September 30, 2024)
- Form of Underwriter Warrant (Filed With SEC on September 30, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on October 12, 2023)
- Form of Tranche A Warrant (Filed With SEC on October 12, 2023)
- Form of Tranche B Warrant (Filed With SEC on October 12, 2023)
- Form of Placement Agent Warrant (Filed With SEC on October 12, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on October 12, 2023)
- Form of Placement Agency Agreement (Filed With SEC on October 12, 2023)
- Form of Registration Rights Agreement (Filed With SEC on October 12, 2023)
- Employment Agreement, dated as of July 29, 2020, by and between enVVeno Medical Corporation and Hamed Alavi (Filed With SEC on March 2, 2023)
- Amendment No. 2 to Amended and Restated 2016 Omnibus Incentive Plan (Filed With SEC on March 28, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on September 8, 2021)
- Form of Placement Agent Warrant (Filed With SEC on September 8, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on September 8, 2021)
- Form of Placement Agency Agreement (Filed With SEC on September 8, 2021)
- At-the-Market Offering Agreement, dated August 12, 2021 (Filed With SEC on August 12, 2021)
- Description of the Companys Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 31, 2021)
- Amendment No. 1 to Amended and Restated 2016 Omnibus Incentive Plan (Filed With SEC on March 31, 2021)
- Employment Agreement, dated as of February 19, 2021, by and between Hancock Jaffe Laboratories, Inc. and Craig Glynn (Filed With SEC on March 31, 2021)
- Form of Warrant Agent Agreement (including Form of Warrant Certificate) (Filed With SEC on February 3, 2021)
- Form of Underwriting Agreement (Filed With SEC on January 28, 2021)
- Form of Warrant Agency Agreement (including Form of Warrant Certificate) (Filed With SEC on January 28, 2021)
- Form of Warrant (Filed With SEC on October 8, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on October 8, 2020)
- Form of Placement Agency Agreement (Filed With SEC on October 8, 2020)
- Form of Warrant Agent Agreement, between the Company and VStock Transfer, LLC (Filed With SEC on July 21, 2020)
- Form of Warrant Agreement (Filed With SEC on July 16, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on July 16, 2020)
- Form of Lock-Up and Voting Agreement (Filed With SEC on July 16, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on July 16, 2020)
- Form of Registration Rights Agreement (Filed With SEC on July 16, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 13, 2020)
- Form of Warrant Agreement (Filed With SEC on July 13, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on July 13, 2020)
- Form of Lock-Up and Voting Agreement (Filed With SEC on July 13, 2020)
- Form of Warrant (Filed With SEC on June 3, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on June 3, 2020)
- Form of Placement Agency Agreement (Filed With SEC on June 3, 2020)
- Form of Warrant (Filed With SEC on April 28, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on April 28, 2020)
- Form of Placement Agency Agreement (Filed With SEC on April 28, 2020)
- Form of Warrant (Filed With SEC on March 2, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on March 2, 2020)
- New Employment Agreement, dated as of July 26, 2019, by and between Hancock Jaffe Laboratories, Inc. and Marc H. Glickman, M.D (Filed With SEC on August 1, 2019)
- Form of Placement Agency Agreement, between the Company and the placement agent (Filed With SEC on June 7, 2019)
- Form of Stock Option Grant under Amended and Restated 2016 Omnibus Incentive Plan (Filed With SEC on March 14, 2019)
- Form of Restricted Stock Unit under Amended and Restated 2016 Omnibus Incentive Plan (Filed With SEC on March 14, 2019)
- Share Purchase Agreement, dated as March 12, 2019, by and among the Company and the investors signatory thereto (Filed With SEC on March 14, 2019)
- Form of Resignation Agreement (Filed With SEC on October 2, 2018)
- Employment Agreement, dated as of July 16, 2018, by and between Hancock Jaffe Laboratories, Inc. and Robert Rankin (Filed With SEC on July 20, 2018)
- Underwriting Agreement, dated May 31, 2018, by and between Hancock Jaffe Laboratories, Inc. and Network 1 Financial Securities, Inc (Filed With SEC on June 6, 2018)
- Form of Promissory Note, original issue discount(May Bridge Note) (Filed With SEC on May 22, 2018)
- Form of Promissory Note, original issue discount and interest (May Bridge Note) (Filed With SEC on May 22, 2018)
- Form of Promissory Note, secured (May Bridge Note) (Filed With SEC on May 22, 2018)
- Form of Share Issuance Agreement (May Bridge Note) (Filed With SEC on May 22, 2018)
- Form of Underwriting Agreement (Filed With SEC on May 14, 2018)
- Form of Warrant Agreement (Filed With SEC on May 14, 2018)
- Form of Warrant Certificate (Filed With SEC on May 14, 2018)
- Amended and Restated 2016 Omnibus Incentive Plan (Filed With SEC on May 14, 2018)
- Second Amendment to Promissory Note , dated April 26, 2018, by and between the Registrant and Leman Cardiovascular S.A. (Leman Note) (Filed With SEC on May 14, 2018)
- Letter Agreement between the Registrant and Benedict Broennimann, M.D (Filed With SEC on May 14, 2018)
- Form of Second Amended and Restated Common Stock Purchase Warrant (issued in connection with the 2017 Notes) (Filed With SEC on April 16, 2018)
- Form of Amended and Restated Common Stock Purchase Warrant (issued in connection with the 2018 Notes) (Filed With SEC on April 16, 2018)
- Amendment to Warrant to Purchase Shares (Filed With SEC on April 16, 2018)
- Second Amendment to Securities Purchase Agreement, dated February 28, 2018, by and among the Registrant and holders signatory thereto (2017 Note) (Filed With SEC on April 16, 2018)
- Form of Second Amended and Restated Convertible Note (2017 Note) (Filed With SEC on April 16, 2018)
- Amendment to Securities Purchase Agreement, dated February 28, 2018, by and among the Registrant and the holders signatory thereto (2018 Note) (Filed With SEC on April 16, 2018)
- Form of Amended and Restated Convertible Note (2018 Note) (Filed With SEC on April 16, 2018)
- First Amendment to Employment Agreement, dated as of April 2, 2018, by and between the Registrant and Benedict Broennimann, M.D (Filed With SEC on April 16, 2018)
- Employment Agreement, dated as of March 30, 2018, by and between the Registrant and Robert A. Berman (Filed With SEC on April 16, 2018)
- Sixth Amendment to Loan Agreement, dated as of January 11, 2018, by and between Biodyne Holding S.A. and the Registrant (Filed With SEC on April 16, 2018)
- Seventh Amendment to Loan Agreement, dated as of March 30, 2018, by and between Biodyne Holding S.A. and the Registrant (Filed With SEC on April 16, 2018)
- Form of Underwriting Agreement (Filed With SEC on January 26, 2018)
- Form of Underwriters Warrant (Filed With SEC on January 26, 2018)
- Form of Amended and Restated Common Stock Purchase Warrant (issued in connection with the 2017 Notes) (Filed With SEC on January 26, 2018)
- Form of Common Stock Purchase Warrant (issued in connection with the 2018 Notes) (Filed With SEC on January 26, 2018)
- Amendment to Securities Purchase Agreement, dated December 29, 2017, by and among the Registrant and the holders signatory thereto (2017 Note) (Filed With SEC on January 26, 2018)
- Form of Amended and Restated Convertible Note (2017 Note) (Filed With SEC on January 26, 2018)
- Form of Securities Purchase Agreement, by and between the Registrant and the holders signatory thereto (2018 Note) (Filed With SEC on January 26, 2018)
- Form of Convertible Note (2018 Note) (Filed With SEC on January 26, 2018)
- Form of Promissory Note (December Note) (Filed With SEC on January 26, 2018)
- Form of Underwriting Agreement (Filed With SEC on December 14, 2017)
- Form of Investors Rights Agreement, by and among the Registrant and investors of Series A Preferred Stock (Filed With SEC on December 14, 2017)
- Form of Investors Rights Agreement, by and among the Registrant and investors of Series B Preferred Stock (Filed With SEC on December 14, 2017)
- Form of Series A Preferred Stock Placement Agents Warrant (Filed With SEC on December 14, 2017)
- Form of Series B Preferred Stock Placement Agents Warrant (Filed With SEC on December 14, 2017)
- Form of Warrant issued under the Note (Filed With SEC on December 14, 2017)
- Form of Underwriters Warrant (Filed With SEC on December 14, 2017)
- Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on December 14, 2017)
- Form of Amendment to 2016 Omnibus Incentive Plan (Filed With SEC on December 14, 2017)
- Form of Indemnification Agreement to be entered into between the Registrant and certain of its directors and officers (Filed With SEC on December 14, 2017)
- Form of Notice of Grant of Stock Option under the 2016 Plan (Filed With SEC on December 14, 2017)
- Form of Senior Secured Convertible Note issued under of the Note (Filed With SEC on December 14, 2017)
- Form of Subscription Agreement (Filed With SEC on December 14, 2017)
- Agreement for Purchase of Corporate Assets, dated May 10, 2013, by and between the Registrant and Leman Cardiovascular S.A (Filed With SEC on December 14, 2017)
- Promissory Note, dated May 10, 2013, by and between the Registrant and Leman Cardiovascular S.A. as amended (Filed With SEC on December 14, 2017)
- Convertible Promissory Note, dated June 26, 2015, by and between the Registrant and Biodyne Holding S.A (Filed With SEC on December 14, 2017)
- Asset Purchase Agreement, dated as of March 18, 2016, by and between LeMaitre Vascular, Inc. and the Registrant (Filed With SEC on November 6, 2017)
- Post-Acquisition Supply Agreement, dated as of March 18, 2016, by and between the Registrant and LeMaitre Vascular, Inc (Filed With SEC on November 6, 2017)
- Development and Manufacturing Agreement, dated as of February 1, 2013, by and between the Registrant and Hancock Jaffe Laboratories Aesthetics, Inc (Filed With SEC on November 6, 2017)
- Medical Advisory Board Agreement, dated as of October 1, 2016, by and between the Registrant and Afksendyios Kalangos, M.D (Filed With SEC on November 6, 2017)
- Standard Industrial/Commercial Single-Tenant Lease, dated as of September 20, 2017, by and between the Registrant and Corbiz, LLC (Filed With SEC on November 6, 2017)
- Loan Agreement, dated as of June 30, 2015, by and between Biodyne Holding S.A. and the Registrant (Filed With SEC on November 6, 2017)
- Fourth Amendment to Loan Agreement, dated as of March 27, 2017, by and between Biodyne Holding S.A. and the Registrant (Filed With SEC on November 6, 2017)
- Fifth Amendment to Loan Agreement, dated as of June 26 , 2017, by and between Biodyne Holding S.A. and the Registrant (Filed With SEC on November 6, 2017)
- Services and Material Supply Agreement, dated as of March 4, 2016, by and between the Registrant and ATSCO, Inc (Filed With SEC on November 6, 2017)
- First Amendment to Employment Agreement, dated as of June 1, 2017, by and between the Registrant and William Abbott (Filed With SEC on November 6, 2017)
- Second Amendment to Employment Agreement, dated as of June 12, 2017, by and between the Registrant and Steven Cantor (Filed With SEC on November 6, 2017)
- Securities Purchase Agreement dated as of June 15, 2017, by and among the Registrant and each purchaser identified on the signature pages thereto (Filed With SEC on November 6, 2017)
- Promissory Note, dated June 15, 2017, by and between the Registrant and Hancock Jaffe Laboratories Aesthetic, Inc (Filed With SEC on November 6, 2017)
- Promissory Note, dated August 22, 2017, by and between the Registrant and Hancock Jaffe Laboratories Aesthetic, Inc (Filed With SEC on November 6, 2017)
- Specimen common stock certificate (Filed With SEC on September 7, 2017)
- 2016 Omnibus Incentive Plan (Filed With SEC on September 7, 2017)
- Employment Agreement, dated as of August 30, 2016, by and between the Registrant and Benedict Broennimann, M.D (Filed With SEC on September 7, 2017)
- Employment Agreement, dated as of July 22, 2016, by and between the Registrant and William R. Abbott (Filed With SEC on September 7, 2017)
- Employment Agreement, dated as of July 22, 2016, by and between the Registrant and Marc Glickman, M.D (Filed With SEC on September 7, 2017)
- Employment Agreement, dated as of July 22, 2016, by and between the Registrant and Susan Montoya (Filed With SEC on September 7, 2017)
- Employment Agreement, dated as of July 1, 2016, by and between the Registrant and Steven Cantor (Filed With SEC on September 7, 2017)
- Medical Advisory Board Agreement, dated as of May 1, 2016, by and between the Registrant and Steve Elias, M.D (Filed With SEC on September 7, 2017)
- Medical Advisory Board Agreement, dated as of May 1, 2016, by and between the Registrant and Antonios Gasparis (Filed With SEC on September 7, 2017)
- Medical Advisory Board Agreement, dated as of September 1, 2016, by and between the Registrant and Wade Dimitri, M.D (Filed With SEC on September 7, 2017)
- Medical Advisory Board Agreement, dated as of October 1, 2016, by and between the Registrant and Mark Meissner, M.D (Filed With SEC on September 7, 2017)
- First Amendment to Loan Agreement, dated as of April 1, 2016, by and between Byodine Holding S.A. and the Registrant (Filed With SEC on September 7, 2017)
- Second Amendment to Loan Agreement, dated as of October 18, 2016, by and between Byodine Holding S.A. and the Registrant (Filed With SEC on September 7, 2017)
- Third Amendment to Loan Agreement, dated as of December 9, 2016, by and between Byodine Holding S.A. and the Registrant (Filed With SEC on September 7, 2017)
- Common Stock Purchase Agreement, dated as of April 1, 2016, by and between the Registrant and Hancock Jaffe Laboratories Aesthetics, Inc (Filed With SEC on September 7, 2017)
- First Amendment to Employment Agreement, dated as of December 1, 2016, by and between the Registrant and Steven Cantor (Filed With SEC on September 7, 2017)